Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Asthma and Allergic Disease

  • Phil Lieberman
Part of the Current Clinical Practice book series (CCP)


Two drugs, cromolyn sodium and nedocromil sodium, are highly effective agents in the therapy of asthma, allergic rhinitis, and allergic eye disease. They exert their beneficial effects through anti-inflammatory mechanisms and thus have been called nonsteroidal anti-inflammatory agents. They are not, however, chemically or by mechanism related to the prostaglandin synthetase inhibitors commonly referred to as nonsteroidal anti-inflammatory drugs.


Allergic Rhinitis Allergic Disease Topical Corticosteroid Sodium Cromoglycate Nedocromil Sodium 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Cherniack RM, Wassermann SI, et al. A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma. CHEST 1990; 97: 1299–1306.Google Scholar
  2. Creticos PS, Norman P, et al. The use of twice daily nedocromil sodium in the treatment of asthma. J Allergy Clin Immunol 1995; 95: 829–836.PubMedCrossRefGoogle Scholar
  3. Edwards AM. Sodium cromoglycate Intal as an anti-inflammatory agent for the treatment of chronic asthma. Clin Exp Allergy 1994; 24: 612–623.PubMedCrossRefGoogle Scholar
  4. Edwards AM, Stevens MT. The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma. Eur Respir J 1993; 6: 35–41.Google Scholar
  5. Global Initiative for Asthma Global Strategy for Asthma Management and Prevention. NHLBI WHO Workshop Report. National Institutes of Health. National Heart, Lung and Blood Institute. Publication No. 953659, January 1995.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Phil Lieberman

There are no affiliations available

Personalised recommendations